A therapeutic anti-PD1 antibody could improve the killing capacity and IFNγ secretion of both Teff and Tex in a co-culture assay with PD-L1 expressing tumor cells, however, Tex functionality remained impaired (Fig. 1h, Supplementary Fig. 1g). This evidence concerns the gene CD274 and neoplasm.